Recombinant Human Urokinase/uPA Protein (His Tag)
Online Inquiry
* Please note that all of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

Recombinant Human Urokinase/uPA Protein (His Tag)

Cat. No : CDRP-00761
size:
Target Information
Target Name Urokinase/uPA
Synonyms Urokinase-Type Plasminogen Activator; U-Plasminogen Activator; uPA; PLAU; ATF; BDPLT5; QPD; u-PA; UPA; URK
UniProt ID P43250-2
Accession NP_002649.1
Product Details
Expression Host Human Cells
Species Human
Tag C-6His
Molar Mass 47.4 kDa
Sequence Ser 112-Ile 195
Background
Recombinant Human Urokinase-Type Plasminogen Activator is a serine protease, which specifically cleaves the zymogen plasminogen to form the active enzyme plasmin. Urokinase-Type Plasminogen Activator is a potent marker of invasion and metastasis in many human cancers associated with breast, colon, stomach, bladder, brain, ovary and endometrium. Human Urokinase-Type Plasminogen Activator is initially synthesized as 431 amino acid precursor with a N-terminal signal peptide residues. The single chain molecule is processed into a disulfide-linked two-chain molecule. There exists two forms A chain, the long A chain contains an EGF-like domain that is responsible for binding of the uPA receptor. The B chain corresponds to the catalytic domain.
Properties
Purity >96% as determined by reducing SDS-PAGE.
Formulation Supplied as a 0.2 μm filtered solution of 20 mM HEPES, 150 mM NaCl, 2 mM CaCl2, 10% Glycerol, pH7.5.
Reconstitution Please refer to the printed manual for detailed information.
Shipping This product is provided as liquid. It is shipped at frozen temperature with blue ice/gel packs.
Storage Store at < -20 °C, stable for 6 months. Please minimize freeze-thaw cycles.

! For research use only. Not intended for any clinical use.